drugset / Trial / NCT04200261
Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem in Clinical Healthy Subjects
RandomizedParallel-groupTriple-blindTreatment
Summary
To observe the pharmacokinetic profiles of benapenem and its major metabolites in healthy volunteers after continuous multiple-dose benapenem, providing evidence for phase Ⅱ/Ⅲclinical study.
Timeline
- Start
- 2019-12-16
- Primary completion
- 2020-09-30
- Completion
- 2020-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Banapenem | Unknown | 2000 mg | — |
| Subject | Banapenem | Unknown | 3000 mg | — |
Indications
No indication recorded.